Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
暂无分享,去创建一个
Claudia Sissi | N. Zaffaroni | M. Palumbo | C. De Marco | G. Zagotto | M. Folini | Giuseppe Zagotto | C. Sissi | Nadia Zaffaroni | Manlio Palumbo | Marco Folini | Cinzia De Marco | Claudia Pivetta | C. Pivetta
[1] Sandy Chang,et al. Telomere dysfunction and tumour suppression: the senescence connection , 2008, Nature Reviews Cancer.
[2] J. Riou,et al. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands. , 2009, European journal of medicinal chemistry.
[3] S. Moro,et al. Mapping Drug Interactions at the Covalent Topoisomerase II-DNA Complex by Bisantrene/Amsacrine Congeners* , 1998, The Journal of Biological Chemistry.
[4] James M. Morrell,et al. Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. , 2004, Bioorganic & medicinal chemistry letters.
[5] David M. Prescott,et al. Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.
[6] Hsu-Shan Huang,et al. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. , 2005, Bioorganic & medicinal chemistry.
[7] T. Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .
[8] J. Mergny,et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] N. Zaffaroni,et al. Targeting the telosome: therapeutic implications. , 2009, Biochimica et biophysica acta.
[10] L. Hurley,et al. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes. , 2003, Journal of medicinal chemistry.
[11] Roger A. Jones,et al. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution , 2006, Nucleic acids research.
[12] Hsu-Shan Huang,et al. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives. , 2008, Bioorganic & medicinal chemistry.
[13] S. Neidle,et al. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.
[14] P. V. von Hippel,et al. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. , 1974, Journal of molecular biology.
[15] S. Moro,et al. DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning. , 1998, Molecular pharmacology.
[16] K. Shin‐ya,et al. The G-Quadruplex Ligand Telomestatin Impairs Binding of Topoisomerase IIIα to G-Quadruplex-Forming Oligonucleotides and Uncaps Telomeres in ALT Cells , 2009, PloS one.
[17] S. Jackson,et al. Human cell senescence as a DNA damage response , 2005, Mechanisms of Ageing and Development.
[18] J. Chiou,et al. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone. , 2003, Journal of medicinal chemistry.
[19] R. Reddel,et al. Telomere maintenance and cancer ? look, no telomerase , 2002, Nature Reviews Cancer.
[20] J. Sedivy,et al. Regulation of growth arrest in senescence: Telomere damage is not the end of the story , 2006, Mechanisms of Ageing and Development.
[21] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[22] Julian Leon Huppert,et al. Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes. , 2008, Chemical Society reviews.
[23] Jean-Louis Mergny,et al. Targeting telomeres and telomerase. , 2008, Biochimie.
[24] Roger A. Jones,et al. Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation , 2007, Nucleic acids research.
[25] M. Stevens,et al. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.
[26] S. Neidle,et al. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. , 1998, Journal of medicinal chemistry.
[27] Stephen Neidle,et al. The structures of quadruplex nucleic acids and their drug complexes. , 2009, Current opinion in structural biology.
[28] S. Neidle,et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.
[29] S. Neidle,et al. G‐quadruplexes as therapeutic targets , 2000, Biopolymers.
[30] Stephen Neidle,et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Mariani,et al. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. , 2006, Cancer research.
[32] S. Mackay,et al. Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase. , 2002, Bioorganic & medicinal chemistry.
[33] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.
[34] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[35] S Neidle,et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. , 1999, Journal of medicinal chemistry.
[36] Hsu-Shan Huang,et al. Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. , 2007, Chemical & pharmaceutical bulletin.
[37] S. Venitt,et al. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity. , 1998, Journal of medicinal chemistry.
[38] James M. Morrell,et al. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. , 2003, Journal of medicinal chemistry.
[39] S. Neidle,et al. Human telomerase inhibition by substituted acridine derivatives. , 1999, Bioorganic & medicinal chemistry letters.
[40] Carlo Leonetti,et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. , 2007, The Journal of clinical investigation.
[41] Stephen Neidle,et al. Structural basis of DNA quadruplex recognition by an acridine drug. , 2008, Journal of the American Chemical Society.
[42] L. Hurley,et al. Accelerated assembly of G-quadruplex structures by a small molecule. , 1999, Biochemistry.
[43] E. Raymond,et al. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.
[44] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[45] Dean W. Felsher,et al. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation , 2007, Proceedings of the National Academy of Sciences.